Scarica l'app Stockscreener
1.47
3.52%
0.05
Precedente Chiudi:
$1.42
Aprire:
$1.43
Volume 24 ore:
250.58K
Relative Volume:
0.35
Capitalizzazione di mercato:
$60.63M
Reddito:
$68.68M
Utile/perdita netta:
$-60.84M
Rapporto P/E:
-0.9188
EPS:
-1.6
Flusso di cassa netto:
$-38.42M
1 W Prestazione:
-2.00%
1M Prestazione:
-24.62%
6M Prestazione:
-4.55%
1 anno Prestazione:
-80.08%
Intervallo 1D:
$1.4122
$1.515
Intervallo di 1 settimana:
$1.375
$1.5583
Portata 52W:
$1.31
$9.37
Pulmonx Corp Stock (LUNG) Company Profile
Nome
Pulmonx Corp
Settore
Industria
Telefono
650-364-0400
Indirizzo
700 CHESAPEAKE DRIVE, REDWOOD CITY
Compare LUNG vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
LUNG
Pulmonx Corp
|
1.47 | 58.57M | 68.68M | -60.84M | -38.42M | -1.60 |
|
ABT
Abbott Laboratories
|
112.68 | 193.83B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
SYK
Stryker Corp
|
366.05 | 140.01B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
99.49 | 129.33B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
BSX
Boston Scientific Corp
|
74.73 | 109.92B | 20.08B | 2.89B | 3.82B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
75.87 | 44.36B | 6.07B | 1.06B | 799.60M | 1.8527 |
Pulmonx Corp Stock (LUNG) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-31 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2025-03-10 | Iniziato | D. Boral Capital | Buy |
| 2024-12-11 | Downgrade | Citigroup | Buy → Neutral |
| 2024-06-04 | Iniziato | Lake Street | Buy |
| 2024-02-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2023-09-05 | Iniziato | Craig Hallum | Buy |
| 2023-02-27 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2023-01-03 | Downgrade | BofA Securities | Neutral → Underperform |
| 2022-12-12 | Aggiornamento | Citigroup | Neutral → Buy |
| 2022-07-11 | Downgrade | Citigroup | Buy → Neutral |
| 2022-03-02 | Ripresa | BofA Securities | Neutral |
| 2021-12-08 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2021-04-01 | Iniziato | Citigroup | Buy |
| 2021-03-25 | Iniziato | Piper Sandler | Neutral |
| 2021-03-10 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2021-01-04 | Downgrade | BofA Securities | Buy → Neutral |
| 2020-10-26 | Iniziato | BofA Securities | Buy |
| 2020-10-26 | Iniziato | Canaccord Genuity | Buy |
| 2020-10-26 | Iniziato | Morgan Stanley | Equal-Weight |
| 2020-10-26 | Iniziato | Stifel | Buy |
| 2020-10-26 | Iniziato | Wells Fargo | Equal Weight |
Mostra tutto
Pulmonx Corp Borsa (LUNG) Ultime notizie
Pulmonx Stock Under Pressure: Can A Niche Lung-Health Innovator Breathe New Life Into Its Shares? - AD HOC NEWS
Will Pulmonx Corporation stock beat EPS estimatesWeekly Risk Summary & Stock Portfolio Risk Control - mfd.ru
Pulmonx (LUNG) Expected to Announce Earnings on Wednesday - Defense World
Merger Talk: Is Pulmonx Corporation a good ESG investment2025 Key Highlights & Free Community Consensus Stock Picks - baoquankhu1.vn
Pulmonx Aktie: Zahlen im Fokus - Börse Global
Pulmonx Q4 2025 Results: A Litmus Test for New Leadership - AD HOC NEWS
Sentiment Watch: Is Pulmonx Corporation a turnaround story2025 Technical Patterns & Weekly Top Gainers Alerts - baoquankhu1.vn
US Market Wrap: Can Cabaletta Bio Inc disrupt its industryJuly 2025 Outlook & Reliable Entry Point Alerts - baoquankhu1.vn
Analyzing Pulmonx (NASDAQ:LUNG) and Privia Health Group (NASDAQ:PRVA) - Defense World
Pulmonx Corporation (NASDAQ:LUNG) Given Average Recommendation of "Hold" by Analysts - MarketBeat
Aug Rallies: How Pulmonx Corporation stock compares to growth peersJuly 2025 Gainers & Reliable Volume Spike Alerts - Bộ Nội Vụ
Why The Pulmonx LUNG Narrative Is Shifting After Target Cut And Leadership Return - Yahoo Finance
Is Pulmonx Corporation stock vulnerable to regulatory risks2025 Price Targets & Weekly High Potential Alerts - Улправда
How Pulmonx Corporation stock valuations compare to rivalsTrade Performance Summary & AI Driven Stock Price Forecasts - Улправда
Pulmonx Corporation (NASDAQ:LUNG) Given Consensus Rating of "Hold" by Brokerages - MarketBeat
Pulmonx Corporation (NASDAQ:LUNG) Given Consensus Rating of “Hold” by Brokerages - Defense World
How Leadership Changes And Analyst Revisions Are Shaping Pulmonx's Valuation Story - Yahoo Finance
Pulmonx (NASDAQ:LUNG) Trading Up 2.5%Here's What Happened - MarketBeat
EBITDA per share of Pulmonx Corp. – GETTEX:4NI - TradingView — Track All Markets
What technical charts say about Pulmonx Corporation stockWeekly Stock Summary & AI Enhanced Trade Execution Alerts - Улправда
Why Pulmonx Corporation stock is in analyst buy zoneJuly 2025 PreEarnings & AI Driven Stock Reports - Улправда
Can Pulmonx Corporation stock hit analyst price targetsDay Trade & Reliable Price Action Trade Plans - Улправда
How strong is Pulmonx Corporation stock revenue growthQuarterly Trade Report & Short-Term High Return Ideas - Улправда
Can Pulmonx Corporation stock resist sector downturnsJuly 2025 Drop Watch & Breakout Confirmation Alerts - Улправда
Will Pulmonx Corporation stock deliver better than expected guidanceJuly 2025 Closing Moves & Community Trade Idea Sharing - Улправда
How Pulmonx Corporation stock performs in interest rate cyclesJuly 2025 Patterns & High Conviction Investment Ideas - Улправда
Will Pulmonx Corporation stock continue upward momentumJuly 2025 Opening Moves & Stepwise Trade Signal Guides - Улправда
Pulmonx Navigates Leadership Shift Amidst Mixed Financial Results - AD HOC NEWS
What New Catalysts Are Shifting the Pulmonx Story for Investors - Yahoo Finance
Comparing Careview Communications (OTCMKTS:CRVW) and Pulmonx (NASDAQ:LUNG) - Defense World
Insider Selling: Daniel Florin Sells Shares of Pulmonx Corp (LUN - GuruFocus
Pulmonx Corp Director Daniel P Florin Sells 23,321 Shares - TradingView — Track All Markets
Check out these key findings about Pulmonx Corp (LUNG) - setenews.com
Dir Florin Files To Sell 23,321 Of Pulmonx Corp [LUNG] - TradingView — Track All Markets
Pulmonx (LUNG) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Improved Revenues Required Before Pulmonx Corporation (NASDAQ:LUNG) Stock's 26% Jump Looks Justified - simplywall.st
Insider Selling: Pulmonx (NASDAQ:LUNG) General Counsel Sells 10,278 Shares of Stock - MarketBeat
Pulmonx (NASDAQ:LUNG) CEO Glendon French III Sells 8,805 Shares - MarketBeat
Pulmonx CEO French sells $13.8k in LUNG stock By Investing.com - Investing.com Australia
Pulmonx CEO French sells $13.8k in LUNG stock - Investing.com India
Pulmonx Corp General Counsel Sells Shares to Cover Tax Obligations - TradingView
LUNG FinancialsIncome Statement - Quiver Quantitative
Pulmonx Corporation Grants 1,625,000 Equity Awards as Part of 2025 Inducement Plan - Quiver Quantitative
Pulmonx (Nasdaq: LUNG) issues 1,625,000-share inducement grants, incl. 1.6M RSUs/PSUs - Stock Titan
Pulmonx Corporation (NASDAQ:LUNG) Given Average Recommendation of “Hold” by Brokerages - Defense World
Pulmonx Corporation (NASDAQ:LUNG) Given Average Recommendation of "Hold" by Brokerages - MarketBeat
Check Out Pulmonx Corp (LUNG)’s Trade Data Rather Than the Analysts’ Views - Setenews
Comparing Pulmonx (NASDAQ:LUNG) and Standard BioTools (NASDAQ:LAB) - Defense World
[S-3/A] Pulmonx Corp Amended Shelf Registration Statement | LUNG SEC FilingForm S-3/A - Stock Titan
[S-8] Pulmonx Corp Employee Benefit Plan Registration | LUNG SEC FilingForm S-8 - Stock Titan
Holdings of Pulmonx Corp (LUNG) are aligned with the stars - setenews.com
Pulmonx Corp Azioni (LUNG) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.33%
0.51%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):